Department of Orthopaedic Surgery, Hoshigaoka Koseinenkin Hospital, 4-8-1 Hoshigaoka, Hirakata City, Osaka, 573-8511, Japan.
Clin Orthop Relat Res. 2010 Apr;468(4):1173-7. doi: 10.1007/s11999-009-1010-8. Epub 2009 Aug 6.
Abnormal reactions accompanied by bone formation in the osteoarticular region induced by long-term administration of etretinate have been reported. We treated a patient who received continuous treatment of psoriatic erythroderma with etretinate for 7 years, and who had an osseous bridge that extended across the acetabulum over the femur on both sides. The patient experienced a major gait disturbance and eventually was unable to walk. Functional gait was restored by resecting the ossified regions and radiotherapy. Histologic sections of the ossified lesions showed enchondral ossification in the ligament attachment site in the joint margin, with advancing ossification along the articular capsule; the pattern was similar to that in diffuse idiopathic skeletal hyperostosis. This is the first report of an osseous bridge associated with long-term administration of etretinate extending across the acetabulum over the femur on both sides.
长期服用依曲替酯可引起骨关节部位伴有骨形成的异常反应。我们治疗了一位接受依曲替酯治疗银屑病红皮病 7 年的患者,该患者双侧股骨髋臼上方有骨性桥横跨髋臼。患者出现严重的步态障碍,最终无法行走。通过切除骨化区域和放疗恢复了功能步态。骨化病变的组织学切片显示关节缘韧带附着处的软骨内骨化,沿着关节囊进行进展性骨化;其模式与弥漫特发性骨肥厚症相似。这是首例双侧股骨髋臼上方的骨性桥与长期服用依曲替酯有关的报告。